Nexalin Technology (NXL) Free Cash Flow (2021 - 2026)
Nexalin Technology's quarterly Free Cash Flow came in at -$1.8 million in Q1 2026, down 23.56% year-on-year from -$2.3 million in Q1 2025, and down 53.5% quarter-over-quarter from -$1.1 million in Q4 2025.
Nexalin Technology has reported Free Cash Flow for 6 years, with the latest figure at -$1.8 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 23.56% year-over-year to -$1.8 million; the trailing twelve-month figure through Mar 2026 stood at -$5.3 million (down 14.9% YoY), and the FY2025 full-year result was -$5.0 million, down 25.69% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$1.8 million, down from -$1.1 million in the prior quarter.
- The five-year high for Free Cash Flow was -$162272.0 in Q2 2022, with the low at -$1.8 million in Q1 2026.
- Average Free Cash Flow over 5 years is -$983258.5, with a median of -$943699.0 recorded in 2022.
- Year-over-year, Free Cash Flow sank 546.75% in 2023 and soared 41.94% in 2024.
- Tracing NXL's Free Cash Flow over 5 years: stood at -$906457.0 in 2022, then decreased by 10.76% to -$1.0 million in 2023, then dropped by 12.99% to -$1.1 million in 2024, then fell by 1.19% to -$1.1 million in 2025, then plunged by 53.5% to -$1.8 million in 2026.
- The last three Free Cash Flow figures came in at -$1.8 million (Q1 2026), -$1.1 million (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 | -1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.76 Mn |
| Mar 31, 2026 | -1.76 Mn |
| Dec 31, 2025 | -1.15 Mn |
| Dec 31, 2025 | -1.15 Mn |
| Sep 30, 2025 | -1.47 Mn |
| Sep 30, 2025 | -1.47 Mn |
| Jun 30, 2025 | -917,165.00 |
| Jun 30, 2025 | -917,165.00 |
| Mar 31, 2025 | -1.43 Mn |
| Mar 31, 2025 | -1.43 Mn |
| Dec 31, 2024 | -1.13 Mn |
| Dec 31, 2024 | -1.13 Mn |
| Sep 30, 2024 | -800,210.00 |
| Sep 30, 2024 | -800,210.00 |
| Jun 30, 2024 | -1.25 Mn |
| Jun 30, 2024 | -1.25 Mn |
| Mar 31, 2024 | -763,289.00 |
| Mar 31, 2024 | -763,289.00 |
| Dec 31, 2023 | -1.00 Mn |
| Dec 31, 2023 | -1.00 Mn |
| Sep 30, 2023 | -701,094.00 |
| Sep 30, 2023 | -701,094.00 |
| Jun 30, 2023 | -815,611.00 |
| Jun 30, 2023 | -815,611.00 |
| Mar 31, 2023 | -1.31 Mn |
| Mar 31, 2023 | -1.31 Mn |
| Dec 31, 2022 | -906,457.00 |
| Dec 31, 2022 | -906,457.00 |
| Sep 30, 2022 | -943,699.00 |
| Sep 30, 2022 | -943,699.00 |
| Jun 30, 2022 | -162,272.00 |
| Jun 30, 2022 | -162,272.00 |
| Mar 31, 2022 | -203,271.00 |
| Mar 31, 2022 | -203,271.00 |
| Dec 31, 2021 | -409,091.00 |
| Dec 31, 2021 | -409,091.00 |